¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦3ÀÚ ¹°·ù ½ÃÀå º¸°í¼­(2025³â)
Biopharmaceutical Third-Party Logistics Global Market Report 2025
»óǰÄÚµå : 1824341
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,457,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,334,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,211,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ÙÀÌ¿ÀÀǾàǰ Á¦3ÀÚ ¹°·ù ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2029³â¿¡´Â CAGR 7.8%¸¦ ³ªÅ¸³» 2,031¾ï 8,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº °³ÀÎÈ­µÈ ÀÇ·áÀÇ ¼ºÀå, »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ È®´ë, °ø±Þ¸ÁÀÇ µðÁöÅÐÈ­, ±ÔÁ¦ ÁؼöÀÇ º¹ÀâÈ­, COVID-19ÀÇ ¿µÇâÀ¸·Î ÀÎÇÑ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿Âµð¸Çµå ¹°·ù ¼Ö·ç¼Ç, ¹°·ù Áö¼Ó¼º, ¸¶Áö¸· ¸¶ÀÏ ¹è¼Û ¼Ö·ç¼Ç, ÀǾàǰ Á÷·ÄÈ­ ¹× ÃßÀû¼º, ÀÚÀ²Àû ¹°·ù µîÀÌ ÀÖ½À´Ï´Ù.

ÇâÈÄ 5³â°£ÀÇ ¼ºÀå·ü 7.8%¶ó°í ÇÏ´Â ¿¹ÃøÀº ÀüȸÀÇ ¿¹ÃøÀ¸·ÎºÎÅÍ 0.2%ÀÇ ¼ÒÆøÀÇ °¨¼Ò¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ÀÌ °¨¼Ò´Â ÁÖ·Î ¹Ì±¹°ú ´Ù¸¥ ±¹°¡ °£ÀÇ °ü¼¼ÀÇ ¿µÇâ ¶§¹®ÀÔ´Ï´Ù. ¹«¿ª ¸¶ÂûÀº µ¶Àϰú ³×´ú¶õµå¿¡¼­ °³¹ßµÈ ¿Âµµ °ü¸®Çü ¿î¼Û ¼Ö·ç¼Ç ¹× ÃßÀû ½Ã½ºÅÛÀÇ °¡°ÝÀ» »ó½Â½ÃÄÑ ÄݵåüÀÎÀÇ ¹«°á¼ºÀ» ÀúÇϽÃŰ°í ¹°·ù ºñ¿ëÀ» Áõ°¡½ÃÄÑ ¹Ì±¹ ÀǾàǰ À¯Åë¿¡ ÁöÀåÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ »óÈ£°ü¼¼¿Í ¹«¿ªÀÇ ±äÀå°ú ÇѰè Áõ°¡·Î ÀÎÇÑ ¼¼°è°æÁ¦¿Í ¹«¿ª¿¡ ´ëÇÑ ¾Ç¿µÇâÀ¸·Î ÀÎÇØ ±× ¿µÇâÀÌ ´õ¿í ±¤¹üÀ§ÇØÁú °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¹°·ù ¾Æ¿ô¼Ò½Ì µ¿Çâ Áõ°¡´Â ¹ÙÀÌ¿ÀÀǾàǰ Á¦3ÀÚ ¹°·ù ½ÃÀå ¼ºÀåÀ» À̲ø °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹°·ù ¾Æ¿ô¼Ò½ÌÀº ±â¾÷ÀÇ ¹°·ù Ȱµ¿ÀÇ ÀüºÎ ¶Ç´Â ÀϺΰ¡ Á¦3ÀÚ¿¡°Ô °ü¸®µÇµµ·Ï ÇÏ´Â °ÍÀ» ÀǹÌÇÕ´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¾ß¿¡¼­´Â ±ØÀú¿Â °ø±Þ¸Á °ü¸®¸¦ ¹°·ù ÆÄÆ®³Ê¿¡°Ô ¾Æ¿ô¼Ò½ÌÇÏ´Â °ÍÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù, ¹Ì±¹ ±³ÅëºÎ(DOT) »êÇÏ ±â°üÀÎ ±³ÅëÅë°è±¹(Bureau of Transportation Statistics)Àº 2023³â 12¿ù À¯»ó È­¹° ¿î¼Û·®ÀÌ 2022³â 12¿ù ´ëºñ 1.8% Áõ°¡Çß´Ù°í º¸°íÇßÀ¸¸ç, È­¹° ¿î¼Û ¼­ºñ½º Áö¼ö(Freight Transportation Services Index)´Â 2022³â 12¿ù 136.6¿¡¼­ 2023³â 12¿ù 139.1·Î »ó½ÂÇß½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¹°·ù ¾Æ¿ô¼Ò½Ì µ¿Çâ Áõ°¡´Â ¹ÙÀÌ¿ÀÀǾàǰ Á¦3ÀÚ ¹°·ù ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Biopharmaceutical third-party logistics involves external partners or services that facilitate the provision of logistics services to pharmaceutical companies. These companies outsource their transportation needs to third-party providers as a cost-saving measure, and the lack of in-house capabilities significantly contributes to the growing trend of transportation outsourcing.

The primary categories of supply chains in biopharmaceutical third-party logistics are cold chain and non-cold chain. The cold chain specifically pertains to a supply chain that ensures temperature control throughout the transportation of products sensitive to temperature variations. Various services, including transportation, warehousing and storage, among others, are utilized by pharmaceutical and biopharmaceutical companies, medical device companies, hospitals and clinics, and other relevant entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The biopharmaceutical third-party logistics market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical third-party logistics market statistics, including biopharmaceutical third-party logistics industry global market size, regional shares, competitors with a biopharmaceutical third-party logistics market share, detailed biopharmaceutical third-party logistics market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical third-party logistics industry. This biopharmaceutical third-party logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biopharmaceutical third-party logistics market size has grown strongly in recent years. It will grow from $141.59 billion in 2024 to $150.5 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to globalization of pharma supply chains, stringent regulatory requirements, rise in biopharmaceuticals, focus on cold chain logistics.

The biopharmaceutical third-party logistics market size is expected to see strong growth in the next few years. It will grow to $203.18 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to personalized medicine growth, biologics and biosimilars expansion, supply chain digitalization, regulatory compliance complexity, COVID-19 impact. Major trends in the forecast period include on-demand logistics solutions, sustainability in logistics, last-mile delivery solutions, pharma serialization and traceability, autonomous logistics.

The forecast of 7.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. drug distribution by inflating prices of temperature-controlled shipping solutions and track-and-trace systems developed in Germany and the Netherlands, resulting in compromised cold chain integrity and higher logistics costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing trend of outsourcing logistics is projected to drive the growth of the biopharmaceutical third-party logistics market. Outsourcing logistics entails engaging a third party to manage all or part of a company's logistical activities. In the biopharmaceutical sector, this practice is utilized for outsourcing cryogenic supply chain management to logistics partners. For instance, in February 2024, the Bureau of Transportation Statistics, a U.S. agency under the Department of Transportation (DOT), reported a 1.8% increase in for-hire freight shipments in December 2023 compared to December 2022, while the Freight Transportation Services Index rose from 136.6 in December 2022 to 139.1 in December 2023. Thus, the increasing trend of outsourcing logistics is expected to propel the growth of the biopharmaceutical third-party logistics market.

The introduction of innovative biopharmaceutical products is anticipated to drive the growth of the biopharmaceutical third-party logistics market. Innovative biopharmaceutical products are advanced and novel therapeutic substances derived from biological sources, such as monoclonal antibodies or gene therapies. The biopharmaceutical third-party logistics market plays a vital role in the efficient launch of these products by providing streamlined supply chain solutions, ensuring timely and secure distribution, and supporting the complex logistics involved in bringing these innovative therapies to market. For instance, in January 2024, the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a U.S. branch of the Food and Drug Administration (FDA), indicated that the CDER approved 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, compared to 37 novel drug approvals in 2022. Therefore, the launch of innovative biopharmaceutical products is expected to propel the growth of the biopharmaceutical third-party logistics market.

Technological advancements stand out as a prominent trend gaining momentum in the biopharmaceutical third-party logistics market. Major companies within this market are strategically launching innovative products to fortify their market position and gain a competitive edge. For example, in November 2022, Celcius Logistics Solutions Pvt Ltd., an India-based logistics services provider, introduced Hyper-Local temperature-controlled delivery services designed for food and pharmaceutical orders. The company's last-mile solution, catering to smaller quantities, is available in nine cities across the country. The hyperlocal approach ensures optimal material quality during transportation by continuously monitoring temperatures in real-time at each stage of the delivery process.

Major companies in the biopharmaceutical third-party logistics market are concentrating on innovative solutions, such as expanding their operations in life sciences and healthcare logistics, to enhance their logistics capabilities for pharmaceutical and healthcare products, ensuring efficient storage and distribution. Business expansion in life sciences and healthcare logistics refers to the strategic growth of logistics companies to improve their capabilities in transporting and managing medical products, which is essential for ensuring timely delivery and maintaining the integrity of temperature-sensitive items crucial for patient care. For example, in August 2022, DHL Supply Chain, a Germany-based contract logistics specialist of Deutsche Post DHL Group, announced the expansion of its Life Sciences and Healthcare Campus in Florstadt, Germany. This expansion includes the construction of a new logistics center that will add 32,000 square meters of space dedicated to the storage and distribution of pharmaceutical and medical products. The facility will feature various temperature-controlled zones and have the capacity for 10,000 pallet locations, enabling it to handle a wide range of pharmaceutical products. This initiative aims to enhance DHL's capabilities in pharmaceutical logistics and support the increasing demands of the healthcare sector, ensuring efficient and compliant handling of sensitive medical supplies.

In March 2022, STG Logistics Inc., a US-based provider of optimized logistics and transportation services, successfully acquired the intermodal division of XPO Logistics Inc. for $710 million. This strategic move enhances STG Logistics' position in the containerized logistics industry, paving the way for further achievements. XPO Logistics Inc. is a US-based provider of asset-based less-than-truckload (LTL) freight transportation and third-party logistics, including biopharma logistics.

Major companies operating in the biopharmaceutical third-party logistics market include McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, Catalent Inc., Almac Group, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics, PCI Pharma Services

North America was the largest region in the biopharmaceutical third party logistics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biopharmaceutical third-party logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biopharmaceutical third-party logistics market consists of revenues earned by entities by providing biopharmaceutical third-party logistics such as domestic transportation management, international transportation management, and value-added warehousing and distribution. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Third-Party Logistics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical third-party logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biopharmaceutical third-party logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical third-party logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Biopharmaceutical Third-Party Logistics Market Characteristics

3. Biopharmaceutical Third-Party Logistics Market Trends And Strategies

4. Biopharmaceutical Third-Party Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biopharmaceutical Third-Party Logistics Growth Analysis And Strategic Analysis Framework

6. Biopharmaceutical Third-Party Logistics Market Segmentation

7. Biopharmaceutical Third-Party Logistics Market Regional And Country Analysis

8. Asia-Pacific Biopharmaceutical Third-Party Logistics Market

9. China Biopharmaceutical Third-Party Logistics Market

10. India Biopharmaceutical Third-Party Logistics Market

11. Japan Biopharmaceutical Third-Party Logistics Market

12. Australia Biopharmaceutical Third-Party Logistics Market

13. Indonesia Biopharmaceutical Third-Party Logistics Market

14. South Korea Biopharmaceutical Third-Party Logistics Market

15. Western Europe Biopharmaceutical Third-Party Logistics Market

16. UK Biopharmaceutical Third-Party Logistics Market

17. Germany Biopharmaceutical Third-Party Logistics Market

18. France Biopharmaceutical Third-Party Logistics Market

19. Italy Biopharmaceutical Third-Party Logistics Market

20. Spain Biopharmaceutical Third-Party Logistics Market

21. Eastern Europe Biopharmaceutical Third-Party Logistics Market

22. Russia Biopharmaceutical Third-Party Logistics Market

23. North America Biopharmaceutical Third-Party Logistics Market

24. USA Biopharmaceutical Third-Party Logistics Market

25. Canada Biopharmaceutical Third-Party Logistics Market

26. South America Biopharmaceutical Third-Party Logistics Market

27. Brazil Biopharmaceutical Third-Party Logistics Market

28. Middle East Biopharmaceutical Third-Party Logistics Market

29. Africa Biopharmaceutical Third-Party Logistics Market

30. Biopharmaceutical Third-Party Logistics Market Competitive Landscape And Company Profiles

31. Biopharmaceutical Third-Party Logistics Market Other Major And Innovative Companies

32. Global Biopharmaceutical Third-Party Logistics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Third-Party Logistics Market

34. Recent Developments In The Biopharmaceutical Third-Party Logistics Market

35. Biopharmaceutical Third-Party Logistics Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â